vs
Forian Inc.(FORA)与IRIDEX CORP(IRIX)财务数据对比。点击上方公司名可切换其他公司
IRIDEX CORP的季度营收约是Forian Inc.的1.8倍($14.7M vs $8.0M),Forian Inc.同比增速更快(37.0% vs -69.7%),过去两年Forian Inc.的营收复合增速更高(27.8% vs 11.9%)
Forian Inc是一家专注于医疗健康领域的数据分析与技术服务商,提供SaaS模式的真实世界证据解决方案、临床决策支持工具及运营优化服务,客户覆盖生物制药企业、医疗机构及生命科学领域相关机构,助力提升诊疗效率、推动医学研究进展。
IRIDEX Corporation是一家全球性医疗科技企业,主要研发、生产和销售面向眼科及医疗美容领域的激光类医疗设备,产品供应至北美、欧洲、亚太等地区的医疗机构与诊所,为眼部疾病治疗和医美项目提供微创解决方案。
FORA vs IRIX — 直观对比
营收规模更大
IRIX
是对方的1.8倍
$8.0M
营收增速更快
FORA
高出106.7%
-69.7%
两年增速更快
FORA
近两年复合增速
11.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $8.0M | $14.7M |
| 净利润 | $-1.8M | — |
| 毛利率 | 49.2% | 37.2% |
| 营业利润率 | -24.4% | — |
| 净利率 | -22.9% | — |
| 营收同比 | 37.0% | -69.7% |
| 净利润同比 | -1012.2% | — |
| 每股收益(稀释后) | $-0.06 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FORA
IRIX
| Q4 25 | $8.0M | $14.7M | ||
| Q3 25 | $7.8M | $12.5M | ||
| Q2 25 | $7.5M | $13.6M | ||
| Q1 25 | $7.1M | $11.9M | ||
| Q4 24 | $5.8M | $12.7M | ||
| Q3 24 | $4.7M | $11.6M | ||
| Q2 24 | $4.8M | $12.6M | ||
| Q1 24 | $4.9M | $11.8M |
净利润
FORA
IRIX
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-151.2K | $-1.6M | ||
| Q2 25 | $224.8K | $-994.0K | ||
| Q1 25 | $-1.1M | $-1.7M | ||
| Q4 24 | $199.7K | $-834.0K | ||
| Q3 24 | $-204.9K | $-1.9M | ||
| Q2 24 | $-2.6M | $-2.7M | ||
| Q1 24 | $-1.2M | $-3.5M |
毛利率
FORA
IRIX
| Q4 25 | 49.2% | 37.2% | ||
| Q3 25 | 51.6% | 32.1% | ||
| Q2 25 | 56.8% | 34.5% | ||
| Q1 25 | 55.6% | 42.5% | ||
| Q4 24 | 58.3% | 44.0% | ||
| Q3 24 | 70.1% | 37.3% | ||
| Q2 24 | 62.2% | 40.7% | ||
| Q1 24 | 65.1% | 37.9% |
营业利润率
FORA
IRIX
| Q4 25 | -24.4% | — | ||
| Q3 25 | -6.1% | -11.3% | ||
| Q2 25 | 0.6% | -6.9% | ||
| Q1 25 | -19.8% | -1.7% | ||
| Q4 24 | -24.9% | -3.9% | ||
| Q3 24 | -17.0% | -16.1% | ||
| Q2 24 | -62.2% | -20.9% | ||
| Q1 24 | -36.3% | -28.0% |
净利率
FORA
IRIX
| Q4 25 | -22.9% | — | ||
| Q3 25 | -1.9% | -12.6% | ||
| Q2 25 | 3.0% | -7.3% | ||
| Q1 25 | -16.0% | -14.2% | ||
| Q4 24 | 3.4% | -6.6% | ||
| Q3 24 | -4.4% | -16.7% | ||
| Q2 24 | -53.4% | -21.2% | ||
| Q1 24 | -24.9% | -29.5% |
每股收益(稀释后)
FORA
IRIX
| Q4 25 | $-0.06 | — | ||
| Q3 25 | $0.00 | $-0.09 | ||
| Q2 25 | $0.01 | $-0.06 | ||
| Q1 25 | $-0.04 | $-0.10 | ||
| Q4 24 | $0.01 | $-0.05 | ||
| Q3 24 | $-0.01 | $-0.12 | ||
| Q2 24 | $-0.08 | $-0.16 | ||
| Q1 24 | $-0.04 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $31.6M | $6.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $29.8M | — |
| 总资产 | $44.1M | $29.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
FORA
IRIX
| Q4 25 | $31.6M | $6.0M | ||
| Q3 25 | $28.2M | $5.6M | ||
| Q2 25 | $35.6M | $6.8M | ||
| Q1 25 | $35.7M | $7.2M | ||
| Q4 24 | $35.1M | $2.4M | ||
| Q3 24 | $49.4M | $3.9M | ||
| Q2 24 | $48.0M | $4.1M | ||
| Q1 24 | $47.4M | $5.4M |
总债务
FORA
IRIX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.0M | ||
| Q3 24 | — | $1.4M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
FORA
IRIX
| Q4 25 | $29.8M | — | ||
| Q3 25 | $31.1M | $4.7M | ||
| Q2 25 | $30.9M | $6.1M | ||
| Q1 25 | $30.0M | $852.0K | ||
| Q4 24 | $30.1M | $2.1M | ||
| Q3 24 | $28.4M | $2.6M | ||
| Q2 24 | $27.2M | $4.2M | ||
| Q1 24 | $28.1M | $6.5M |
总资产
FORA
IRIX
| Q4 25 | $44.1M | $29.2M | ||
| Q3 25 | $41.3M | $28.4M | ||
| Q2 25 | $48.5M | $31.6M | ||
| Q1 25 | $48.6M | $34.2M | ||
| Q4 24 | $47.2M | $29.1M | ||
| Q3 24 | $57.5M | $30.2M | ||
| Q2 24 | $58.4M | $31.2M | ||
| Q1 24 | $57.5M | $34.1M |
负债/权益比
FORA
IRIX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.48× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $3.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
FORA
IRIX
| Q4 25 | $3.2M | — | ||
| Q3 25 | $-439.7K | $-1.2M | ||
| Q2 25 | $-344.5K | $-397.0K | ||
| Q1 25 | $448.2K | $-1.1M | ||
| Q4 24 | $1.7M | $-1.2M | ||
| Q3 24 | $764.1K | $-3.1M | ||
| Q2 24 | $-23.1K | $-1.3M | ||
| Q1 24 | $-2.2M | $-1.6M |
自由现金流
FORA
IRIX
| Q4 25 | — | — | ||
| Q3 25 | — | $-1.2M | ||
| Q2 25 | — | $-410.0K | ||
| Q1 25 | — | $-1.2M | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | — | $-3.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-1.7M |
自由现金流率
FORA
IRIX
| Q4 25 | — | — | ||
| Q3 25 | — | -9.4% | ||
| Q2 25 | — | -3.0% | ||
| Q1 25 | — | -9.8% | ||
| Q4 24 | — | -9.8% | ||
| Q3 24 | — | -26.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -14.0% |
资本支出强度
FORA
IRIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 0.0% | 0.1% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.0% | 0.0% |
现金转化率
FORA
IRIX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.53× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 8.76× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FORA
| Financial Services Revenues | $7.3M | 92% |
| Other | $669.0K | 8% |
IRIX
暂无分部数据